Prosecution Insights
Prosecution Insights
5 pending office actions • 4 art units • 5 examiners • 0 of 5 (0%) have an AI response strategy ready • 12 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 5 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 5 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (20%) |
| §112 only | 2 (40%) |
| No statute on record | 2 (40%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BENAVIDES, JENNIFER ANN | 1 | 50.0% | +44.9% |
| STEADMAN, DAVID J | 1 | 57.7% | +29.4% |
| HOLLAND, PAUL J | 1 | 57.5% | +64.7% |
| PAGUIO FRISING, MICHELLE F | 1 | 70.5% | +40.7% |
| BARRON, SEAN C | 1 | 53.5% | +30.9% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19071055 | PH20 POLYPEPTIDE VARIANTS, FORMULATIONS AND USES THEREOF | HOLLAND, PAUL J | 141d overdue |
| 19071264 | PH20 POLYPEPTIDE VARIANTS, FORMULATIONS AND USES THEREOF | STEADMAN, DAVID J | 125d overdue |
| 18332893 | DOSING REGIMEN | PAGUIO FRISING, MICHELLE F | 36d overdue |
| 19358181 | METHODS OF TREATING TUMORS | BENAVIDES, JENNIFER ANN | 2d overdue |
| 18059135 | COMPOSITIONS OF ADENOSINE DEAMINASE-2 (ADA2), VARIANTS THEREOF AND METHODS OF USING SAME | BARRON, SEAN C | 16d |
| Art Unit | Apps |
|---|---|
| 1656 | 2 |
| 1675 | 1 |
| 1651 | 1 |
| 1653 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19358181 | METHODS OF TREATING TUMORS | BENAVIDES, JENNIFER ANN | 1675 | Other | Non-Final OA | 2d overdue | Pending | Oct 14, 2025 |
| 19071264 | PH20 POLYPEPTIDE VARIANTS, FORMULATIONS AND USES THEREOF | STEADMAN, DAVID J | 1656 | §112 | Non-Final OA | 125d overdue | Pending | Mar 05, 2025 |
| 19071055 | PH20 POLYPEPTIDE VARIANTS, FORMULATIONS AND USES THEREOF | HOLLAND, PAUL J | 1656 | §112 | Non-Final OA | 141d overdue | Pending | Mar 05, 2025 |
| 18332893 | DOSING REGIMEN | PAGUIO FRISING, MICHELLE F | 1651 | §103 | Non-Final OA | 36d overdue | Pending | Jun 12, 2023 |
| 18059135 | COMPOSITIONS OF ADENOSINE DEAMINASE-2 (ADA2), VARIANTS THEREOF AND METHODS OF USING SAME | BARRON, SEAN C | 1653 | Other | Final Rejection | 16d | Pending | Nov 28, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial